Itopride Therapy
Itopride Therapy is a pharmacological prokinetic intervention that specifically enhances gastrointestinal motility through dual inhibition of acetylcholinesterase and blockade of dopamine D2 receptors, distinguishing it from other prokinetic agents by its unique dual-mode mechanism of action.
41
Publications
1.9K
Citations
214
Authors
82
Institutions
Publications per year
2017–2026
7
Parents
41
A Placebo-Controlled Trial of Itopride in Functional Dyspepsia
Gerald Holtmann, Nicholas J. Talley, Tobias Liebregts et al. · New England Journal of Medicine · 2006 · 239 citations
A placebo-controlled trial of itopride in functional dyspepsia.
Thierry Piche · 2006 · 190 citations
1–5 of 41
214
6
h-index
3
h-index
3
h-index
3
h-index
3
h-index
1–5 of 214
82
KU Leuven
Leuven, Belgium
4 h-index
18 publications
810 citations
Yonsei University
Seoul, South Korea
3 h-index
7 publications
170 citations
Gunma University
Maebashi, Japan
2 h-index
3 publications
141 citations

The University of Adelaide
Adelaide, Australia
2 h-index
7 publications
294 citations

Macquarie University
Sydney, Australia
2 h-index
2 publications
78 citations
Wonkwang University
Iksan, South Korea
2 h-index
2 publications
115 citations

Universitair Ziekenhuis Leuven
Leuven, Belgium
2 h-index
2 publications
90 citations
WinnMed
Decorah, United States
2 h-index
3 publications
254 citations
1–8 of 82
Repository · 5 publications · 187 citations
5
h-index
4 publications · 149 citations
4
h-index
2 publications · 117 citations
2
h-index
2 publications · 90 citations
2
h-index
2 publications · 96 citations
2
h-index
1–5